NDC 25021-466

Octreotide Acetate

Octreotide Acetate

Octreotide Acetate is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Octreotide Acetate.

Product ID25021-466_1eb44289-a226-4ed0-b5d3-d0f090f5a58b
NDC25021-466
Product TypeHuman Prescription Drug
Proprietary NameOctreotide Acetate
Generic NameOctreotide Acetate
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2022-12-31
Marketing CategoryANDA /
Application NumberANDA091041
Labeler NameSagent Pharmaceuticals
Substance NameOCTREOTIDE ACETATE
Active Ingredient Strength200 ug/mL
Pharm ClassesSomatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 25021-466-05

1 VIAL in 1 CARTON (25021-466-05) > 5 mL in 1 VIAL
Marketing Start Date2022-12-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Octreotide Acetate" or generic name "Octreotide Acetate"

NDCBrand NameGeneric Name
0641-6174Octreotide AcetateOctreotide Acetate
0641-6175Octreotide AcetateOctreotide Acetate
76135-009OCTREOTIDE ACETATEOCTREOTIDE ACETATE
76135-005Octreotide AcetateOctreotide Acetate
76135-006Octreotide AcetateOctreotide Acetate
76135-010OCTREOTIDE ACETATEOCTREOTIDE ACETATE
76135-011OCTREOTIDE ACETATEOCTREOTIDE ACETATE
0641-6177Octreotide AcetateOctreotide Acetate
0641-6178Octreotide AcetateOctreotide Acetate
0641-6176Octreotide AcetateOctreotide Acetate
0703-3301Octreotide AcetateOctreotide Acetate
0703-3311Octreotide AcetateOctreotide Acetate
0703-3321Octreotide AcetateOctreotide Acetate
0703-3343Octreotide AcetateOctreotide Acetate
0703-3333Octreotide AcetateOctreotide Acetate
0781-3168Octreotide AcetateOctreotide Acetate
0781-3167Octreotide AcetateOctreotide Acetate
0781-3164Octreotide AcetateOctreotide Acetate
0781-3166Octreotide AcetateOctreotide Acetate
0781-3165Octreotide AcetateOctreotide Acetate
25021-452Octreotide AcetateOctreotide Acetate
25021-451Octreotide AcetateOctreotide Acetate
25021-454Octreotide AcetateOctreotide Acetate
25021-455Octreotide AcetateOctreotide Acetate
25021-453Octreotide AcetateOctreotide Acetate
55648-633Octreotide acetateOctreotide acetate
55648-632Octreotide acetateOctreotide acetate
55648-636Octreotide acetateOctreotide acetate
55648-635Octreotide acetateOctreotide acetate
55648-634Octreotide acetateOctreotide acetate
64679-633Octreotide acetateOctreotide acetate
64679-636Octreotide acetateOctreotide acetate
64679-632Octreotide acetateOctreotide acetate
64679-634Octreotide acetateOctreotide acetate
64679-635Octreotide acetateOctreotide acetate
67457-246Octreotide AcetateOctreotide Acetate
67457-245Octreotide AcetateOctreotide Acetate
67457-239Octreotide AcetateOctreotide Acetate
0078-0180Sandostatinoctreotide acetate
0078-0181Sandostatinoctreotide acetate
0078-0182Sandostatinoctreotide acetate
0078-0183Sandostatinoctreotide acetate
0078-0184Sandostatinoctreotide acetate
0078-0647Sandostatin LAR Depotoctreotide acetate
0078-0648Sandostatin LAR Depotoctreotide acetate
0078-0811Sandostatin LAR Depotoctreotide acetate
0078-0818Sandostatin LAR Depotoctreotide acetate
0078-0825Sandostatin LAR Depotoctreotide acetate

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.